Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07285252

Evaluating Non-Invasive Haptics During Extreme Exercise

This study aims to compare determinants of endurance performance between participants wearing an active patch with haptic vibrotactile trigger technology (VTT) versus a placebo patch without VTT among recreational to competitive runners over a 4-week training period.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

VO2max Lactate Lactate Threshold

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Altitude Centre

London, UK, E1 6AH, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years and over, that participate in recreational to competitive distance running (>2 structured runs per week), that were able to complete maximal treadmill exercise safely and were able to attend three laboratory visits were invited to participate.

Exclusion criteria

  • Adults with a contraindications to high-intensity treadmill exercise, cardiovascular, metabolic, or musculoskeletal conditions limiting participation, reported use of performance-enhancing drugs, pregnancy, known allergy to adhesives, or current use of neuromodulatory or haptic devices

Treatment and study plan

Victory Patch with Haptic Vibrotactile Trigger Technology

Device

Active Patch with Haptic Vibrotactile Trigger Technology

Sham Patch

Device

Sham/Placebo Patch without Haptic Vibrotactile Trigger Technology

Primary outcomes

  1. Change in VO2 Max

    Time frame: 2-weeks and 4-weeks after baseline assessment

    Change in VO₂max (mL/kg-¹/min-¹, calculated as a 30-second rolling average)

Secondary outcomes

  1. Change in Lactate-threshold running speed

    Time frame: 2-weeks and 4-weeks after baseline assessment

    Measurement of Lactate-threshold running speed using capillary sampling (LT, km/h-¹), determined using a DmodMax algorithm on lactate-speed curves [15], (2) serum lactate level at threshold (mmol·L-¹).

Sponsors and collaborators

Lead sponsor

SuperPatch Limited LLC

Industry

Collaborators

  • Clarity Science LLC
  • The Altitude Centre
  • Vichag Healthcare Research

Registry information

Official study title

ENDURE- Evaluating Non-Invasive Haptics During Extreme Exercise

Acronym: ENDURE

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 16, 2025
Registry last updated
Dec 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.